Endometrial cancer in premenopausal women 45 years and younger
References (25)
- et al.
The epidemiology of endometrial cancer
Gynecol Oncol
(1991) - et al.
Carcinoma of the endometrium
Am J Obstet Gynecol
(1973) Hormone therapy following breast and uterine cancer
Baillieres Clin Endocrinol Metab
(1993)- et al.
Effects of long-term estrogen replacement therapy: I. Metabolic effects
Am J Obstet Gynecol
(1979) - et al.
Estrogen therapy following treatment for stage I endometrial carcinoma
Gynecol Oncol
(1990) - et al.
Endometrial carcinoma in women 40 years of age or younger
Obstet Gynecol
(1981) Carcinoma of the endometrium in women under forty years of age
Obstet Gynecol
(1958)- et al.
Adenocarcinoma of the endometrium in women 40 years of age or younger
Obstet Gynecol
(1984) Prognosis of endometrial carcinoma
Obstet Gynecol
(1969)- et al.
Carcinoma of the endometrium in premenopausal women
Am J Obstet Gynecol
(1969)
Endometrial cancer in women under 40 years of age
Cancer
(1977)
Carcinoma of the endometrium III. Analysis of 865 cases of adenocarcinoma and adenoacanthoma
Obstet Gynecol
(1982)
Cited by (179)
Impact of abnormal uterine bleeding care in premenopausal patients prior to endometrial malignancy diagnosis
2023, Gynecologic Oncology ReportsUterine Cancer
2019, Abeloff’s Clinical OncologyHormone-Responsive Cancers
2019, Yen & Jaffe's Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management: Eighth EditionChange in hazard rates of recurrence over time following diagnosis of endometrial cancer: An age stratified multicentre study from the FRANCOGYN group
2018, European Journal of Surgical OncologyAnalysis of endometrial carcinoma in young women at a high-volume cancer center
2017, International Journal of SurgeryCitation Excerpt :Previous studies have reported the incidence of concurrent ovarian tumors among young women with EC in the range of 5–29% [5,15,16,18,21,34,35]. Gitsch et al. reported the highest rate of concurrent ovarian malignancy (29%) in the literature, but the number of patients in the study was extremely small (n = 17); in their research, occult metastasis in normal-appearing ovaries appeared was only evident in one patient [18]. In Walsh et al.’s study, the rate of coexisting ovarian malignancy in young women with EC was 25% [35].
Fertility-sparing management of endometrial cancer and atypical hyperplasia
2017, Gynecologie Obstetrique Fertilite et Senologie
Copyright © 1995 Published by Elsevier Inc.